Gabrielle Gardian
Affiliations: | Neurology | University of Pécs, Hungary, Pécs, Hungary |
Google:
"Gabrielle Gardian"Mean distance: 17.48 (cluster 28)
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Gárdián G. (2006) Animal models of Huntington's disease. Ideggyã³Gyã¡Szati Szemle. 59: 396-9 |
Kiaei M, Petri S, Kipiani K, et al. (2006) Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 26: 2467-73 |
Klivenyi P, Siwek D, Gardian G, et al. (2006) Mice lacking alpha-synuclein are resistant to mitochondrial toxins. Neurobiology of Disease. 21: 541-8 |
Gardian G, Browne SE, Choi DK, et al. (2005) Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease. The Journal of Biological Chemistry. 280: 556-63 |
Klivenyi P, Gardian G, Calingasan NY, et al. (2004) Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity. Neuromolecular Medicine. 6: 87-92 |
Gardian G, Yang L, Cleren C, et al. (2004) Neuroprotective effects of phenylbutyrate against MPTP neurotoxicity. Neuromolecular Medicine. 5: 235-41 |
Gárdián G, Vécsei L. (2004) Huntington's disease: pathomechanism and therapeutic perspectives. Journal of Neural Transmission (Vienna, Austria : 1996). 111: 1485-94 |
Klivenyi P, Starkov AA, Calingasan NY, et al. (2004) Mice deficient in dihydrolipoamide dehydrogenase show increased vulnerability to MPTP, malonate and 3-nitropropionic acid neurotoxicity. Journal of Neurochemistry. 88: 1352-60 |
Klivenyi P, Kiaei M, Gardian G, et al. (2004) Additive neuroprotective effects of creatine and cyclooxygenase 2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neurochemistry. 88: 576-82 |
Klivenyi P, Gardian G, Calingasan NY, et al. (2003) Additive neuroprotective effects of creatine and a cyclooxygenase 2 inhibitor against dopamine depletion in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) mouse model of Parkinson's disease. Journal of Molecular Neuroscience : Mn. 21: 191-8 |